Klingman & Associates, LLC Pfizer Inc Transaction History

Klingman & Associates, LLC

$1.61 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $96,233 - $110,506	-3,717 Reduced 30.73%	8,379 $232,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $9,955 - $12,931	-381 Reduced 3.05%	12,096 $348,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $10,332 - $12,078	-322 Reduced 2.52%	12,477 $413,000
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $8,199 - $9,486	-227 Reduced 1.74%	12,799 $469,000
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $9,335 - $12,153	-237 Reduced 1.79%	13,026 $531,000
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $30,060 - $39,240	720 Added 5.74%	13,263 $679,000
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $14,659 - $17,895	-335 Reduced 2.6%	12,543 $549,000
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $21,543 - $25,543	-463 Reduced 3.47%	12,878 $675,000
Q1 2022 May 06, 2022	BUY	$45.75 - $56.69 $210,404 - $260,717	4,599 Added 52.61%	13,341 $690,000
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $1,983 - $2,940	-48 Reduced 0.55%	8,742 $516,000
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $44,705 - $57,428	-1,139 Reduced 11.47%	8,790 $378,000
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $535,525 - $606,660	-14,913 Reduced 60.03%	9,929 $389,000
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $26,624 - $30,027	795 Added 3.31%	24,842 $900,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $340,925 - $433,516	10,186 Added 73.49%	24,047 $885,000
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $57,435 - $67,385	1,809 Added 15.01%	13,861 $509,000
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $11,445 - $13,885	-380 Reduced 3.06%	12,052 $394,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $6,973 - $9,963	-258 Reduced 2.03%	12,432 $406,000
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $13,365 - $15,168	406 Added 3.31%	12,690 $497,000
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $2,566 - $3,328	-79 Reduced 0.64%	12,284 $441,000
Q2 2019 Sep 27, 2019	BUY	$36.98 - $41.52 $233,861 - $262,572	6,324 Added 104.72%	12,363 $536,000
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $225,393 - $253,064	-6,095 Reduced 50.23%	6,039 $262,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $107,908 - $123,027	-2,805 Reduced 18.78%	12,134 $530,000
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $45,259 - $54,896	1,313 Added 9.64%	14,939 $658,000
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $20,183 - $21,517	-612 Reduced 4.3%	13,626 $494,000
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $9,892 - $11,476	310 Added 2.23%	14,238 $505,000
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $3,924 - $4,164	-118 Reduced 0.84%	13,928 $504,000
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $435,426 - $479,670	14,046	14,046 $501,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.

Account